STOCK TITAN

Camp4 Therapeutics Corp. Stock Price, News & Analysis

CAMP Nasdaq

Welcome to our dedicated page for Camp4 Therapeutics news (Ticker: CAMP), a resource for investors and traders seeking the latest updates and insights on Camp4 Therapeutics stock.

CAMP4 Therapeutics Corporation (Nasdaq: CAMP) is a clinical-stage biopharmaceutical company developing regulatory RNA-targeting therapeutics designed to upregulate gene expression and restore healthy protein levels in genetic diseases. The CAMP news feed highlights how the company advances its antisense oligonucleotide (ASO) pipeline, progresses clinical and preclinical programs, and enters strategic collaborations.

Readers can follow CAMP4’s updates on its SYNGAP1-related disorders program, including announcements about GLP toxicology studies for CMP-SYNGAP-01, translational data in humanized mouse models and non-human primates, and plans for Phase 1/2 clinical trial applications. News items also cover the company’s Urea Cycle Disorders program and the CMP-CPS-001 (CMP-001) Phase 1 trial, where CAMP4 has reported safety and pharmacokinetics data from single and multiple ascending dose cohorts in healthy volunteers.

CAMP4’s news flow includes financial and corporate updates such as private placements, underwritten offerings of common stock, and use of proceeds to support development of its product candidates. The company also reports on strategic agreements, including a research, collaboration and license agreement with GSK to discover and develop ASO drug candidates for neurodegenerative and kidney disease indications using CAMP4’s RAP Platform.

In addition, CAMP4 issues press releases on scientific presentations at major meetings, corporate highlights, and inducement grants under Nasdaq Listing Rule 5635(c)(4). Investors and observers can use this news page to review CAMP4’s reported milestones, research progress, and financing activities related to its regulatory RNA-targeting therapeutic strategy.

Rhea-AI Summary

Toyota Spain has partnered with LoJack España, a subsidiary of CalAmp, to enhance stolen vehicle recovery services for its customers. The collaboration will allow Toyota's dealer network to market LoJack SVR services directly, utilizing advanced tracking technology capable of functioning in challenging environments. The service aims to improve customer security and offers 24/7 support from a dedicated control center. This partnership also extends to Toyota's leasing and insurance services, further integrating LoJack into their offerings for various models.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.22%
Tags
partnership
-
Rhea-AI Summary

CalAmp has appointed Mark Gaydos as its new chief marketing officer, effective immediately. Gaydos, with over 25 years of experience in enterprise software marketing, will oversee the company's global marketing strategy and efforts to boost demand for its connected intelligence solutions. His previous roles include leading marketing at Nlyte Software and Engine Yard, where he achieved significant revenue growth. CalAmp aims to enhance its position as a leading software-as-a-service provider in the transportation and logistics sectors, capitalizing on increasing cloud-connected operations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.36%
Tags
management
-
Rhea-AI Summary

CalAmp (Nasdaq: CAMP) announced that its President and CEO, Jeff Gardner, along with CFO Kurt Binder, will present at the 24th Annual Needham Growth Conference on January 11, 2022, at 2:45 a.m. ET. The event will be held virtually, allowing management to engage with investors throughout the day. Interested parties can request a meeting via email. A live webcast and archived presentation will be available on CalAmp's Investor Relations website following the event. CalAmp specializes in providing connected intelligence solutions across various industries.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.69%
Tags
conferences
Rhea-AI Summary

CalAmp (CAMP) has appointed Basudeb Chatterjee as Chief Digital Information Officer (CDIO). With over 15 years of experience in digital transformations across industries, Chatterjee will oversee IT functions globally, focusing on data, infrastructure, and information security. His role includes guiding technology adoption and enhancing CalAmp's connected intelligence solutions. CEO Jeff Gardner expressed confidence in Chatterjee's ability to drive innovations that will strengthen competitiveness. Chatterjee aims to foster agile teams dedicated to maximizing the value of CalAmp's SaaS offerings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.41%
Tags
management
-
Rhea-AI Summary

CalAmp (Nasdaq: CAMP) has announced the departure of Arym Diamond, SVP and Chief Revenue Officer, effective January 14, 2022. Maurizio Iperti, President of EMEA, will take over as interim CRO. Iperti has a successful track record in transforming SaaS companies, which will aid in maintaining business operations during the transition. CEO Jeff Gardner expressed confidence in Iperti's capabilities to provide market-leading insights and solutions while the search for a permanent CRO begins.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.14%
Tags
none
-
Rhea-AI Summary

CalAmp (CAMP) reported its Q3 FY2022 results, revealing a 12% decline in total revenue to $69 million year-over-year, primarily due to global component shortages. While Software and Subscription Services (S&SS) revenue increased by 7% to $37 million, Telematics Products revenue fell by 14% to $32 million. The company faced a net loss of $11 million or $0.30 per share, compared to a loss of $3.7 million the prior year. Despite challenges, CalAmp maintains a strong customer backlog and ended the quarter with $91 million in cash.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-25.78%
Tags
Rhea-AI Summary

CalAmp (Nasdaq: CAMP) will release its fiscal 2022 third quarter financial results after market close on December 21, 2021. A conference call is scheduled for 5:00 p.m. Eastern on the same day to discuss the results, accessible via the company's website or by phone. The call will provide crucial insights into the company's performance, with a replay available for 90 days. Established in 1983 and based in Irvine, California, CalAmp specializes in connected intelligence solutions, boasting nearly one million subscribers and over 20 million products installed globally.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.91%
Tags
conferences earnings
-
Rhea-AI Summary

On December 1, 2021, CalAmp (Nasdaq: CAMP) announced a partnership between its subsidiary, LoJack España, and the car subscription service Bipi, enhancing Bipi's fleet operations with connected car solutions. This collaboration aims to improve preventative fleet maintenance and facilitate stolen vehicle recovery through advanced technologies. Bipi, which has served over 10,000 customers in three years, offers flexible, all-inclusive car subscriptions without long-term commitments. This partnership positions Bipi for future growth amidst vehicle shortages across Europe.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.87%
Tags
none
-
Rhea-AI Summary

CalAmp (Nasdaq: CAMP) provided a business update regarding supply chain constraints and the transition to software subscriptions. CEO Jeff Gardner announced a 10% decline in projected revenues for Q3 FY2022, ending November 30, due to reduced telematics product shipments and lower software revenues from a completed retrofit project. Despite short-term challenges, customer demand remains strong, with ongoing progress in transitioning telematics clients to subscription-based contracts. Financial results will be disclosed on December 21, 2021.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.01%
Tags
Rhea-AI Summary

CalAmp (Nasdaq: CAMP), a leader in connected intelligence, announced participation in two upcoming virtual investor conferences:

  • Craig-Hallum 12th Annual Alpha Select Conference on November 16, 2021, featuring 1x1 conference calls with management.
  • ROTH 10th Annual Technology Event on November 18, 2021, also with management calls.

Portfolio managers and analysts can arrange calls through their sales representatives or CalAmp's investor relations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.47%
Tags
conferences

FAQ

What is the current stock price of Camp4 Therapeutics (CAMP)?

The current stock price of Camp4 Therapeutics (CAMP) is $5.33 as of March 18, 2026.

What is the market cap of Camp4 Therapeutics (CAMP)?

The market cap of Camp4 Therapeutics (CAMP) is approximately 284.3M.

CAMP Rankings

CAMP Stock Data

284.31M
42.98M
Biotechnology
Pharmaceutical Preparations
Link
United States
CAMBRIDGE

CAMP RSS Feed